Ngm Biopharmaceuticals (NGM)

Company Profile

ngm bio is a research-driven, clinical stage biopharmaceutical company with a drug discovery platform designed to generate a pipeline of first-in-class biologic drug candidates. our initial r&d focus has been on cardio-metabolic and liver disease, but we believe that our research expertise – comprehensive and grounded in fundamental, interrelated mechanisms of human biology – is capable of driving the development of new therapies for a wide range of disease areas such as cancer. ngm bio’s comprehensive approach to drug discovery focuses on elucidating the biology of hormones, cell receptors and associated ligands. as we investigate these novel biological mechanisms, we assemble a deep understanding of the relationship between the structure and function of proteins of interest. coupled with our experience in protein and antibody engineering, our approach enables the efficient and targeted generation of potential first-in-class therapeutics with optimized pharmacologic profiles. work

Company profile

Ticker

NGM

Exchange

NASDAQ

Website

www.ngmbio.com/

CEO

David Woodhouse

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Bausch Health Companies • Celgene ...

SEC CIK

0001426332

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

NGM Biopharmaceuticals Australia Pty Ltd. ...

NGM stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

2 Nov 23

NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights

2 Nov 23

8-K

Departure of Directors or Certain Officers

17 Oct 23

8-K/A

Departure of Directors or Certain Officers

11 Sep 23

8-K

Departure of Directors or Certain Officers

11 Aug 23

EFFECT

Notice of effectiveness

7 Aug 23

424B5

Prospectus supplement for primary offering

4 Aug 23

S-3/A

Shelf registration (amended)

4 Aug 23

3 Aug 23

NGM Bio Reports Second Quarter 2023 Financial Results and Provides Business Highlights

3 Aug 23

Latest ownership filings

View all

Change in insider ownership

17 Nov 23

Change in insider ownership

Financial summary

Financial statements Chart NGM financial data

Quarter (USD)	Sep 23	Jun 23	Mar 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	56.93 mm	56.93 mm	56.93 mm	56.93 mm	56.93 mm	56.93 mm
Cash burn (monthly)	98.33 k	4.04 mm	10.34 mm	13.34 mm	9.05 mm	11.64 mm
Cash used (since last report)	210.96 k	8.67 mm	22.19 mm	28.62 mm	19.43 mm	24.97 mm
Cash remaining	56.72 mm	48.26 mm	34.74 mm	28.31 mm	37.50 mm	31.96 mm
Runway (months of cash)	576.8	11.9	3.4	2.1	4.1	2.7

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2023

NGM institutional ownership history Ownership history

74.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	96	108	-11.1%
Opened positions	12	12	–
Closed positions	24	27	-11.1%
Increased positions	30	41	-26.8%
Reduced positions	35	37	-5.4%

13F shares	Current	Prev Q	Change
Total value	49.20 bn	120.33 bn	-59.1%
Total shares	61.65 mm	62.54 mm	-1.4%
Total puts	300.00	1.20 k	-75.0%
Total calls	400.00	2.40 k	-83.3%
Total put/call ratio	0.8	0.5	+50.0%

Largest owners	Shares	Value	Change
Column	18.14 mm	$19.41 bn	0.0%
Column Group L P	11.20 mm	$146.09 mm	0.0%
EcoR1 Capital	6.44 mm	$6.89 bn	0.0%
BLK Blackrock	3.84 mm	$4.11 bn	-17.1%
Topspin Fund	3.32 mm	$77.67 mm	0.0%
Vanguard	2.76 mm	$2.95 bn	-1.2%
StepStone	1.57 mm	$1.68 bn	0.0%
JPM JPMorgan Chase & Co.	1.41 mm	$1.51 bn	+158.6%
Acadian Asset Management	1.19 mm	$1.28 mm	+4.8%
Euclidean Capital	992.17 k	$1.06 bn	+32.9%

Largest transactions	Shares	Bought/sold	Change
JPM JPMorgan Chase & Co.	1.41 mm	+867.20 k	+158.6%
BLK Blackrock	3.84 mm	-793.13 k	-17.1%
MS Morgan Stanley	477.24 k	-420.89 k	-46.9%
Bridgeway Capital Management	275.00 k	+275.00 k	NEW
Renaissance Technologies	522.33 k	+269.73 k	+106.8%
Euclidean Capital	992.17 k	+245.49 k	+32.9%
Deutsche Bank AG - Registered Shares	0.00	-231.92 k	EXIT
Dimensional Fund Advisors	207.90 k	-230.64 k	-52.6%
Citadel Advisors	164.15 k	-182.34 k	-52.6%
Nuveen Asset Management	623.79 k	-157.55 k	-20.2%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

NGM insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
16 Nov 23	David V Goeddel	Common Stock	Buy	Acquire P	Yes	No	0.6211	5,840	3.63 k	949,862
16 Nov 23	David V Goeddel	Common Stock	Buy	Acquire P	No	No	0.6211	1,460	906.81	134,180
16 Nov 23	Column Group L P	Common Stock	Buy	Acquire P	Yes	No	0.6211	5,840	3.63 k	949,862
16 Nov 23	Column Group L P	Common Stock	Buy	Acquire P	Yes	No	0.6211	5,840	3.63 k	949,862
16 Nov 23	Column Group L P	Common Stock	Buy	Acquire P	Yes	No	0.6211	5,840	3.63 k	949,862
15 Nov 23	David V Goeddel	Common Stock	Buy	Acquire P	Yes	No	0.7075	16,791	11.88 k	944,022
15 Nov 23	David V Goeddel	Common Stock	Buy	Acquire P	No	No	0.7054	2,720	1.92 k	132,720
15 Nov 23	Column Group L P	Common Stock	Buy	Acquire P	Yes	No	0.7075	16,791	11.88 k	944,022
15 Nov 23	Column Group L P	Common Stock	Buy	Acquire P	Yes	No	0.7075	16,791	11.88 k	944,022
15 Nov 23	Column Group L P	Common Stock	Buy	Acquire P	Yes	No	0.7075	16,791	11.88 k	944,022